COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Study to Evaluate the Safety, Tolerability and Pharmacokinetics of PBTZ169 in Multiple Dosing

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03776500
Recruitment Status : Completed
First Posted : December 14, 2018
Last Update Posted : October 22, 2020
Bill and Melinda Gates Foundation
Information provided by (Responsible Party):
Innovative Medicines for Tuberculosis

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : March 20, 2020
Actual Study Completion Date : March 20, 2020